Denmark finds haemodialysis less expensive:
This article was originally published in Clinica
Executive Summary
The cost of hospital-based haemodialysis is not much greater than peritoneal dialysis carried out at home, reveals a new study from researchers at Odense University in Denmark. The researchers, from the university's Centre for Health Service Research and Social Policy, calculated that the difference in cost between haemodialysis and peritoneal dialysis is only DKr15,000-DKr130,000 ($2,140-$18,570) and not as much as DKr200,000 as was previously thought. Since haemodialysis is cheaper and peritoneal dialysis more expensive than had been assumed, treatment decisions should be taken on purely clinical grounds, advise the researchers in Ugeskrift for Laeger.
You may also be interested in...
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.
Finance Watch: Canaan, Regeneron Reveal New Funds For Start-Ups
Private Company Edition: Regeneron launched a $500m venture fund and Canaan added $100m, bringing the venture firm’s recent total to $1bn-plus. Also, incubators plan to grow over the next decade and in recent financings Avenzo raised $150m and Nvelop launched with $100m.
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.